Related Experiment Video
Updated: Apr 1, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Heterogeneity of HLH pathophysiology and treatment strategies]
Takahiro Yasumi1, Hirofumi Shibata, Saeko Shimodera
1Department of Pediatrics, Kyoto University Graduate School of Medicine.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by immune dysregulation and hyperinflammation and is histologically characterized by the presence of benign hemophagocytic macrophages. HLH is classified as primary or secondary depending on the underlying etiology and includes conditions with various pathophysiological features. The pathogenic mechanisms underlying the different HLH subtypes remain incompletely understood and therapeutic regimens for HLH are devised on empirical bases. Herein, recent advances in the understanding of HLH pathogenesis and potential strategies for subtype-specific HLH treatment are reviewed.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by immune dysregulation and hyperinflammation and is histologically characterized by the presence of benign hemophagocytic macrophages. HLH is classified as primary or secondary depending on the underlying etiology and includes conditions with various pathophysiological features. The pathogenic mechanisms underlying the different HLH subtypes remain incompletely understood and therapeutic regimens for HLH are devised on empirical bases. Herein, recent advances in the understanding of HLH pathogenesis and potential strategies for subtype-specific HLH treatment are reviewed.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets
Hedgehog Signaling Pathway

